EX-21.1 5 ex211to10k20231231.htm EX-21.1 Document

Exhibit 21.1



Subsidiaries of Lisata Therapeutics, Inc.
Entity (1)
Percentage of OwnershipLocation
Athelos Corporation (2)
99%United States of America
Lisata Therapeutics Australia Pty Ltd100%Australia
Lisata Therapeutics Ireland Limited100%Ireland
Lisata Therapeutics KK100%Japan
Lisata Therapeutics (U.K.) Limited100%United Kingdom

(1) Subsidiaries listed are as of the Company's filing date of February 29, 2024.
(2) As of December 31, 2023, Becton Dickinson's ownership interest in Athelos Corporation was 1.0%.